Biotricity Inc., a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, is aiming to change cardiac healthcare into a preventive and cost-savings model that leverages precise biometrics and actionable feedback to motivate patient adherence.
With increased adherence, the company believes “that patients with existing chronic conditions can better manage their health and prevent the onset of co-morbid conditions while facilitating a reduction in healthcare costs.”
We learned this week that Biotricity is developing a spectrum of real-time and high-precision remote patient monitoring solutions (RPM). The company’s premier product, Bioflux, is a high-precision, single-unit mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ambulatory patients’ ECG information.
With shorter time gaps between follow-up appointments, RPM devices can increase patient adherence by shortening the feedback loop and enabling patients to take the necessary action to mitigate negative health outcomes.
“When patients can track their progress, and see how certain choices have a direct and positive impact on their health, they are more likely to adhere to treatment plans, engage in their healthcare, and change their behavior,” said Waqaas Al Siddiq, Biotricity Founder and CEO.